Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 31, 2015
Pharmacy Choice - News - Over-the-Counter Drugs - January 31, 2015

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 28     Next >>     Go To Page:

1/30/15 - Have we become too dependent on medication? [Yerepouni Daily News (Armenia)]
A 2010 survey from The Henry J. Kaiser Family Foundation revealed that between 1999 and 2009, the number of prescriptions dispensed in the US increased by 39%, from 2.8 billion to 3.9 billion. A 2014 survey from the Centers for Disease Control and Prevention revealed 48% of us have used at least one prescription drug in the past 30 days- 5% more th
1/29/15 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Labeling Regulations
All comments should be identified with the OMB control number 0910-0485. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
1/29/15 - Capillus Mobile LLLT Device for Hair Regrowth Receives FDA Clearance
Miami- based medical device manufacturer, Capillus, LLC, announces that the Capillus272? has received 510 clearance from the Food and Drug Administration. "We received excellent results from our clinical trial," says Carlos Pia, Capillus CEO. "It is very gratifying to receive FDA clearance for our Capillus272 Laser," says Dr.
1/29/15 - PREZCOBIX? (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1
Janssen Therapeutics, Division of Janssen Products, LP, today announced the U.S. Food and Drug Administration has approved PREZCOBIX? tablets, an HIV-1 protease inhibitor combined with a CYP3A4 inhibitor, for the treatment of human immunodeficiency virus in combination with other antiretroviral agents for treatment-naive and treatment-experienc
1/28/15 - EU Approves Novartis-Glaxo Business Swap, With Concessions
Brussels- The EU gave a green light Wednesday to a business swap between pharmaceutical giants Novartis and GlaxoSmithKline, but required the companies to give up some of their business to preserve competition. Swiss medicine group Novartis is buying the cancer drug branch of British rival GSK for 16 billion dollars, while GSK will in turn acquire
1/28/15 - Galmed and Perrigo Execute Manufacturing Agreement for Large-Scale Aramchol API Production
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it has entered into a Manufacturing Services Agreement with Perrigo API Ltd., a subsidiary of Perrigo Company
1/28/15 - Innovus Pharma Expands Its Men's Health Franchise with the Addition of Exclusive Rights to Androferti to Support Overall Male Reproductive Health and Sperm Quality for the U.S. and Canadian Market
San Diego, CA 01/28/2015 Innovus Pharmaceuticals, Inc., an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and vitality, announced today that it entered into an exclusive distribution agreement with Laboratorios
1/28/15 - Innovus Pharma Expands its Men's Health Franchise with the Addition of Exclusive Rights to Androferti(R) to Support Overall Male
Innovus Pharma Expands its Men's Health Franchise with the Addition of Exclusive Rights to Androferti (R) to Support Overall Male Reproductive Health and Sperm Quality for the U.S. and Canadian Market. SAN DIEGO, CA/ ACCESSWIRE/ January 28, 2015/ Innovus Pharmaceuticals, Inc., an emerging commercial stage pharmaceutical company that delivers safe,.
1/28/15 - Moberg Pharma gets Chinese approval for Kerasal Nail [EMBIN (Emerging Markets Business Information News]
Swedish pharmaceutical firm Moberg Pharma's partner Menarini Asia-Pacific has received approval to market for its fungal nail product in China. The eight Southeast Asian countries include Singapore, Taiwan, Indonesia, Philippines, Malaysia, Hong Kong, Thailand and Vietnam. Additionally, Menarini has started launch activities of the product in Malay
1/28/15 - Perrigo Launches AB Therapeutic Equivalent Testosterone Gel 1.0%
By a News Reporter-Staff News Editor at Biotech Week Perrigo Company plc announced that it has launched its AB therapeutic equivalent testosterone gel 1.0%. The Food and Drug Administration concluded previously that Perrigo's testosterone product is therapeutically equivalent to AbbVie's AndroGel 1.0% and can be substituted with the full...
1/28/15 - Uphold spirit of Medicines Policy [New Straits Time (Malaysia)]
In support of the concept of Essential Medicines, a model list of essential drugs, which included about 200 generic drugs and vaccines, was prepared by the World Health Organisation in 1977.. Most WHO member states welcomed the new approach to medicines and Malaysia is no exception. The concept of essential medicines had been adopted in Malaysia's
1/28/15 - Vertex Reports Full-Year and Fourth Quarter 2014 Financial Results and Provides Guidance for 2015
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the full-year and quarter ended December 31, 2014. The 2014 GAAP net loss was $739 million, or $3.14 per share, which includes net charges of $227 million. As of December 31, 2014, Vertex had approximately $1.4 billion in cash, cash equivalents and marketable secu
1/27/15 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Class II Special Controls Guidance...
All comments should be identified with the OMB control number 0910-0633. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
1/27/15 - Boston Therapeutics' Hong Kong Affiliate Receives Department of Health Certificate to Initiate SUGARDOWN(R) Clinical Trial
Boston Therapeutics, Inc. today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd., received a signed certificate from the Department of Health to initiate a clinical trial at The Chinese University of Hong Kong evaluating SUGARDOWN in subjects with pre-diabetes. David Platt, Ph.D., CEO of Boston Therapeutics, said, "We
1/27/15 - Novo Nordisk Receives FDA Approval for Norditropin FlexPro 30 mg/3.0 mL for Patients with Growth Hormone Disorders
Novo Nordisk announced today the U.S. Food and Drug Administration approval of Norditropin FlexPro 30 mg/3. 0 mL, a prefilled injection pen for patients with growth hormone-related disorders. "Novo Nordisk is committed to advancing growth hormone delivery devices with patients in mind," said Eddie Williams, senior vice president, Biopharma
1/27/15 - Oral Thin Films Market, 2015 - 2025
INTRODUCTION Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets/ capsules to modern-day fast disintegrating and rapidly acting tablets/ films, the market has come a long way. Some of the key players in this area include MonoSol Rx, Applied Pharma Research/ Labtec GmbH, BioDelivery S
1/27/15 - Perrigo Company plc Announces Quarterly Dividend
From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ingredients, and...
1/26/15 - Axion Power Announces the Appointment of Donald F. Farley to its Board of Directors
By a News Reporter-Staff News Editor at Pharma Business Week Axion Power International, Inc., a developer of advanced lead-carbon PbC batteries, energy storage systems and frequency regulation systems, announced that Donald F. Farley, 72, has been appointed to its Board of Directors, effective January 10, 2015. As president of Farley& Associat
1/26/15 - China to allow online sales of prescription drugs this month [China Daily: Africa Weekly]
A customer shops at a pharmacy in Xuchang, Henan province March 8, 2014. China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc.. The new policy could eventually allow online retail pharm
1/26/15 - Clinical Trail Finds Kids' Growth Impacted by Intranasal Corticosteroids
An Allegheny Health Network clinical trial examining whether intranasal corticosteroids stunt children's growth the first such trial conducted in accordance with U.S. Food and Drug Administration guidelines- found a small but statistically significant growth reduction for children taking the medication to treat allergic rhinitis, or hay fever.
1/26/15 - Hysingla? ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available
Hysingla ER is the first and only hydrocodone product to be recognized by the U.S. Food& Drug Administration as having abuse-deterrent properties that are expected to deter misuse and abuse via chewing, snorting and injection.However, abuse of Hysingla ER by the intravenous, intranasal, and oral routes is still possible. "We're already seeing sign
1/26/15 - Perrigo Launches The Generic Version Of Clobex Clobetasol Propionate Spray, 0.05%
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex Spray, 0.05%. The launch date was agreed upon in a litigation settlement between Perrigo and Galderma Laboratories, L.P. Perrigo's mission is to offer uncompromised "Q
1/26/15 - Shire Comments on FDA Approval of Natpara
Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA Dublin, Ireland- January 23, 2015- Shire plc notes the announcement today by NPS Pharmaceuticals, Inc. that the U.S. Food and Drug Administration has approved NATPARA as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroid
1/26/15 - Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone)
Release date- 23012015- Dublin, Ireland- Shire plc notes the announcement today by NPS Pharmaceuticals, Inc. that the U.S. Food and Drug Administration has approved NATPARA as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. Shire's Chief Executive Officer, Flemming Ornskov, MD, MPH, commented:.
1/26/15 - SHIRE PLC - Shire Comments on FDA Approval of Natpara
Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA Dublin, Ireland- January 23, 2015- Shire plc notes the announcement today by NPS Pharmaceuticals, Inc. that the U.S. Food and Drug Administration has approved NATPARA as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroid
Articles(s): 1 - 25 of 28     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Drug Therapy Management Series Part I: Cardiovascular Disorders
This lesson is supported by:
RxSchool
Workplace Safety & Joint Commission Standards for Pharmacy Professionals
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415